Innovative Cell Technologies, Inc.
↗San Diego, United States
Innovative Cell Technologies, Inc. (ICT) is a biotechnology company based in San Diego, California, specializing in the development and manufacturing of high-quality cell detachment and dissociation reagents for life science research and clinical applications. The company is best known for its flagship products, Accutase® and Accumax™, which serve as non-mammalian, non-bacterial alternatives to traditional enzymes like trypsin and collagenase for cell culture and flow cytometry applications.
Founded over 25 years ago, the company operates under an ISO 13485:2016 quality control system and maintains an FDA-reviewed Drug Master File (DMF). Their products are widely utilized in stem cell research, regenerative medicine, and bioprocessing, supported by extensive scientific literature and a reputation for enhancing cell viability and reproducibility in laboratory workflows.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2001
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Reagent Manufacturer)
Modalities:Cell Culture Reagents
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various global distributors for life science reagents
COMPETITION
Position:Niche Player
Competitors:Thermo Fisher Scientific, Merck KGaA (Sigma-Aldrich), Corning
LEADERSHIP
Key Executives:
C. Kevin Becker - President
Margie Becker - Co-owner
LINKS
Website:innovativecelltech.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Innovative Cell Technologies, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Innovative Cell Technologies, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.